Lymphoma clinical trials in New York
42 studies for Lymphoma are looking for participants at sites in New York.
Cities in New York
- New York City33 studies
- Queens10 studies
- Greenburgh9 studies
- Staten Island8 studies
- New Rochelle7 studies
- Buffalo6 studies
- Rochester5 studies
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07015242Epco, Zanu, Ritux for R/R FL or MZL
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06563596Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, East White Plains
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT02974647Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT04301076Collection of Tissue Samples for Cancer Research
- Roswell Park Cancer Institute, Buffalo
RecruitingObservational study
2 Months · All sexes · Updated Sep 16, 2026 · NCT00900198Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Cornell, New York
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, New York
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Roswell Park Cancer Institute, Buffalo
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Rochester
RecruitingPhase 3
Ages 18 to 18 · All sexes · Updated Sep 8, 2026 · NCT07509151A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Stony Brook Univ Cancer Ctr, Stony Brook
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06624085TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07082803A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Hematology Oncology Associates of Central New York, East Syracuse
- University of Rochester, Rochester
- Stony Brook University Hospital Cancer Center, Stony Brook
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06084936Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT05389293Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- New York Medical College, Valhalla
RecruitingPhase 1/2
Ages 13 to 90 · All sexes · Updated Aug 6, 2026 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
- Memorial Sloan Kettering, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07465835A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Call for Information (Investigational Site 0031), New York
RecruitingPhase 1/2
6 Months – 17 Years · All sexes · Updated Jul 6, 2026 · NCT02332668CD4CAR for CD4+ Leukemia and Lymphoma
- Albert Einstein Health Network, New York
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Jun 24, 2026 · NCT03829540A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05475925A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 5, 2026 · NCT07137494Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
- Columbia University Irving Medical Center, New York
RecruitingPhase 2
Ages 15 and older · All sexes · Updated May 27, 2026 · NCT06954805A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- and 1 more
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT07052916Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2
Up to age 26 · All sexes · Updated May 14, 2026 · NCT07566377CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078Study of CAR-T Therapy in Older Patients
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 60 and older · All sexes · Updated Apr 7, 2026 · NCT04300998A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
RecruitingPhase 2
Ages 18 to 66 · All sexes · Updated Mar 17, 2026 · NCT06859424Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT06510361A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT06698003Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingObservational study
Ages 18 and older · Women · Updated Mar 4, 2026 · NCT01788839BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT06854003ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
- Columbia University, New York
Recruiting
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT06693830Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jan 23, 2026 · NCT00582621Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Noyes Memorial Hospital/Myers Cancer Center, Dansville
- Northwell Health/Center for Advanced Medicine, Lake Success
- Highland Hospital, Rochester
- and 3 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 13, 2026 · NCT05006482CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06420089Umbilical Cord Blood Transplantation From Unrelated Donors
- Wilmot Cancer Institute, Rochester
RecruitingObservational study
2 Months – 75 Years · All sexes · Updated Oct 10, 2025 · NCT03016806From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.